MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TGTX made $616,287K in revenue. $447,179K in net income. Net profit margin of 72.56%.

Income Overview

Revenue
$616,287K
Net Income
$447,179K
Net Profit Margin
72.56%
EPS
$2.77
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • International
    • License
Revenue Breakdown
    • Product
    • Royalty
    • Other Revenue
    • License Revenue

Income Statement
2025-12-31
2024-12-31
Revenue
616,287 329,004
Cost of revenue
100,714 38,486
Noncash compensation
16,618 11,160
Other research and development
143,597 83,131
Total research and development
160,215 94,291
Noncash compensation
48,053 31,381
Other selling, general and administrative
183,981 122,917
Total selling, general and administrative
232,034 154,298
Total costs and expenses
492,963 -
Operating income
123,324 41,929
Interest expense
26,727 24,028
Other income
10,793 7,693
Total other expense
-15,934 -16,335
Net income before taxes
107,390 25,594
Income tax benefit (expense)
-339,789 2,211
Net income
447,179 23,383
Basic EPS
3.1 0.16
Diluted EPS
2.77 0.15
Basic Average Shares
144,316,786 145,317,418
Diluted Average Shares
161,412,746 160,336,051
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
US$594,105K International$12,823K Product$606,928K (93.46%↑ Y/Y)License$9,359K Revenue$616,287K (87.32%↑ Y/Y)Operating income$123,324K (194.13%↑ Y/Y)Total costs andexpenses$492,963K Income tax benefit(expense)-$339,789K (-15468.11%↓ Y/Y)Net income beforetaxes$107,390K (319.59%↑ Y/Y)Total other expense-$15,934K (2.45%↑ Y/Y)Other income$10,793K (40.30%↑ Y/Y)Total selling,general and...$232,034K (50.38%↑ Y/Y)Total research anddevelopment$160,215K (69.92%↑ Y/Y)Cost of revenue$100,714K (161.69%↑ Y/Y)Net income$447,179K (1812.41%↑ Y/Y)Interest expense$26,727K (11.23%↑ Y/Y)Other selling,general and...$183,981K (49.68%↑ Y/Y)Noncash compensation$48,053K (53.13%↑ Y/Y)Other research anddevelopment$143,597K (72.74%↑ Y/Y)Noncash compensation$16,618K (48.91%↑ Y/Y)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)